{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:36:58Z","timestamp":1792629418594,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Care Clinics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ccc.2013.03.014","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T21:15:38Z","timestamp":1372972538000},"page":"699-715","source":"Crossref","is-referenced-by-count":83,"title":["Urinary Tract Infection"],"prefix":"10.1016","volume":"29","author":[{"given":"Lindsay E.","family":"Nicolle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccc.2013.03.014_bib1","first-page":"3550","article-title":"Contrasting treatments and outcomes of septic shock presentation on hospital floors versus emergency department","volume":"123","author":"Wang","year":"2010","journal-title":"Chin Med J"},{"key":"10.1016\/j.ccc.2013.03.014_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/CCM.0b013e3181eb3ccd","article-title":"Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis","volume":"38","author":"Kumar","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.resuscitation.2009.03.008","article-title":"Australian resuscitation of sepsis evaluation (ARISE): a multi-centre, prospective, inception cohort study","volume":"80","author":"Peake","year":"2009","journal-title":"Resuscitation"},{"key":"10.1016\/j.ccc.2013.03.014_bib4","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1097\/CCM.0b013e31821b827c","article-title":"Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality","volume":"39","author":"Zahar","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1399-6576.2011.02437.x","article-title":"Severe sepsis and septic shock: a prospective population-based study in Icelandic intensive care units","volume":"55","author":"Vesteinsdottir","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.ccc.2013.03.014_bib6","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1464-410X.2006.06450.x","article-title":"One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study","volume":"98","author":"Mariappan","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ccc.2013.03.014_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.urology.2010.03.025","article-title":"One week of nitrofurantoin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study","volume":"77","author":"Bag","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.ccc.2013.03.014_bib8","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1684-1182(10)60031-X","article-title":"Impact of extended spectrum \u03b2-lactamase producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections","volume":"43","author":"Yang","year":"2010","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s15010-009-8460-5","article-title":"Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes","volume":"38","author":"Cohen-Nahum","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.ccc.2013.03.014_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jmii.2011.11.007","article-title":"Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes","volume":"45","author":"Chen","year":"2012","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jmii.2011.09.029","article-title":"Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase producing Escherichia coli or Klebsiella pneumoniae and their emergence in the community","volume":"45","author":"Lee","year":"2012","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s10156-011-0289-z","article-title":"Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER","volume":"18","author":"Lee","year":"2012","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.ccc.2013.03.014_bib13","first-page":"235","article-title":"Are blood cultures necessary in the management of women with complicated pyelonephritis?","volume":"53","author":"Chen","year":"2006","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/clinids\/14.1.15","article-title":"Renal ultrasonographic correlates of acute pyelonephritis","volume":"14","author":"Johnson","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.014_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ajic.2010.03.022","article-title":"Clinical significance of nosocomial acquisition in urinary tract-related bacteremia caused by gram-negative bacilli","volume":"39","author":"Kang","year":"2011","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ccc.2013.03.014_bib16","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/cc3023","article-title":"Intensive care unit acquired urinary tract infections in a regional critical care system","volume":"9","author":"Laupland","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.ccc.2013.03.014_bib17","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/cid\/cis252","article-title":"Both host and pathogen factors predispose to Escherichia coli urinary source bacteremia in hospitalized patients","volume":"54","author":"Marschall","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.014_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/665323","article-title":"Healthcare-associated bloodstream infections secondary to a urinary focus. The Quebec Provincial Surveillance Results","volume":"33","author":"Fortin","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ccc.2013.03.014_bib19","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/662378","article-title":"Epidemiology of hospital-acquired urinary tract-related bloodstream infection at a University hospital","volume":"32","author":"Chang","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ccc.2013.03.014_bib20","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.archger.2010.05.011","article-title":"Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection patients","volume":"52","author":"Chin","year":"2011","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.ccc.2013.03.014_bib21","first-page":"296","article-title":"Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection","volume":"50","author":"Tal","year":"2005","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1464-410X.2009.08414.x","article-title":"Emergency nephrectomy due to severe urosepsis: a retrospective, multicenter analysis of 65 cases","volume":"104","author":"Berger","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ccc.2013.03.014_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AAC.05753-11","article-title":"Bacteremia caused by extended-spectrum-\u03b2-lactamase-producing Escherichia coli sequence ST 131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality","volume":"56","author":"Chung","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccc.2013.03.014_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijmm.2012.03.002","article-title":"Virulence factors and phylogenetic grouping of Escherichia coli isolates from patients with bacteremia of urinary tract origin related to sex and hospital- vs. community-acquired origin","volume":"302","author":"Skjot-Rasmussen","year":"2012","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.ccc.2013.03.014_bib25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: Importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.014_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/313583","article-title":"Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases Mycoses Study Group","volume":"30","author":"Kauffman","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.014_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11739-011-0707-3","article-title":"Clinical characteristics and outcomes of patients with extended-spectrum \u03b2-lactamase-producing bacteremia in the emergency department","volume":"6","author":"Lin","year":"2011","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib28","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.CCM.0000168253.91200.83","article-title":"The International Sepsis Forum Consensus Conference on definitions of infection in the intensive care unit","volume":"33","author":"Calandra","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/sur.2007.023","article-title":"Fever and leukocytosis in critically ill trauma patients. It\u2019s not the urine","volume":"9","author":"Golob","year":"2008","journal-title":"Surg Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib30","first-page":"1254","article-title":"Chronic indwelling catheter replacement prior to antimicrobial therapy for symptomatic urinary infection","volume":"164","author":"Raz","year":"2000","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ccc.2013.03.014_bib31","doi-asserted-by":"crossref","first-page":"R206","DOI":"10.1186\/cc9328","article-title":"Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective, observational study","volume":"14","author":"Van Nieuwkoop","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.ccc.2013.03.014_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0022-3859.65291","article-title":"Genitourinary imaging: current and emerging applications","volume":"56","author":"O\u2019Donoghue","year":"2010","journal-title":"J\u00a0Postgrad Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2165\/00003088-200746040-00003","article-title":"Pharmacokinetic characteristics of antimicrobials and optimal treatment of urosepsis","volume":"46","author":"Wagenlehner","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ccc.2013.03.014_bib34","article-title":"Guidelines on urological infections","author":"Grabe","year":"2011","journal-title":"Eur Assoc of Urology"},{"issue":"Suppl","key":"10.1016\/j.ccc.2013.03.014_bib35","first-page":"S494","article-title":"Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review","volume":"32","author":"Boxchud","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib36","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1128\/AAC.00837-08","article-title":"Intravenous doripenem at 500 mg vs levofloxacin at 250 mg with an option to switch to oral therapy for treatment of complicated lower urinary tract infection and pyelonephritis","volume":"53","author":"Naber","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl S2","key":"10.1016\/j.ccc.2013.03.014_bib37","doi-asserted-by":"crossref","first-page":"ii67","DOI":"10.1093\/jac\/dkh208","article-title":"Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicenter trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy","volume":"53","author":"Wells","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccc.2013.03.014_bib38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jac\/17.4.517","article-title":"Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs cefotaxime in the treatment of complicated urinary tract infections","volume":"17","author":"Naber","year":"1986","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccc.2013.03.014_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/AAC.38.3.415","article-title":"Cefepime compared with ceftazidime as initial therapy for serious bacterial infections and sepsis syndrome","volume":"38","author":"Kieft","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ccc.2013.03.014_bib40","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/jac\/dkq224","article-title":"Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase producing Escherichia coli","volume":"65","author":"Geerlings","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ccc.2013.03.014_bib41","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1345\/aph.1K346","article-title":"Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series","volume":"42","author":"Pastewski","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccc.2013.03.014_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.014_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2007.09.002","article-title":"A\u00a0double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400\/500 mg twice daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis","volume":"71","author":"Peterson","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.ccc.2013.03.014_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","article-title":"Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomized open-label and double-blind placebo-controlled non-inferiority trial","volume":"380","author":"Sandberg","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ccc.2013.03.014_bib45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3349\/ymj.2010.51.4.569","article-title":"Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage","volume":"51","author":"Lee","year":"2010","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.ccc.2013.03.014_bib46","first-page":"1474","article-title":"Emphysematous pyelonephritis","volume":"107","author":"Ubec","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.ccc.2013.03.014_bib47","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/0036554021000027015","article-title":"Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991\u20132000)","volume":"35","author":"Kim","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ccc.2013.03.014_bib48","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1469-0691.2011.03606.x","article-title":"The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study","volume":"18","author":"Lye","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ccc.2013.03.014_bib49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/pgmj.2010.116616","article-title":"Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community-acquired bacteremia","volume":"87","author":"Hoounsom","year":"2011","journal-title":"Postgrad Med J"},{"issue":"Suppl","key":"10.1016\/j.ccc.2013.03.014_bib50","first-page":"13","article-title":"Epidemiology and outcome of bacteremia caused by extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp in a tertiary care teaching hospital in South India","volume":"58","author":"Abhilash","year":"2010","journal-title":"J\u00a0Assoc Physicians India"},{"key":"10.1016\/j.ccc.2013.03.014_bib51","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1553-2712.2009.00468.x","article-title":"Risk factors for mortality of bacteremic patients in the emergency department","volume":"16","author":"Lin","year":"2009","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ccc.2013.03.014_bib52","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00134-010-1851-3","article-title":"The influence of infection sites on development and mortality of ARDS","volume":"36","author":"Sheu","year":"2010","journal-title":"Intensive Care Med"}],"container-title":["Critical Care Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070413000377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749070413000377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T22:41:20Z","timestamp":1715640080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749070413000377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0749070413000377"],"URL":"https:\/\/doi.org\/10.1016\/j.ccc.2013.03.014","relation":{},"ISSN":["0749-0704"],"issn-type":[{"value":"0749-0704","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}